Nasus Pharma appoints Nir Sassi as CFO
Nasus Pharma (NSRX) announced Monday the appointment of Nir Sassi as chief financial officer, effective November 11, 2026.
The company noted that Sassi most recently served as CFO of Indaptus Therapeutics. Previously, he served as CFO of Intec Pharma and began his professional
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.